Tiludronate

Tiludronic acid (INN) or Tiludronate (USAN), marketed as under the brand name Skelid®, is a bisphosphonate used to treat Paget's disease.

Administration
Tiludronic acid is administered orally. The recommended dose is a single 400-mg daily oral dose, taken with 6 to 8 ounces of plain water only, should be administered for a period of 3 months. Beverages other than plain water (including mineral water), food (see below), and some medications are likely to reduce the tiludronic acid's absorption.